Chinese Markets for Ovarian Cancer Treatment Drugs : Market Research Report

Chinese Markets for Ovarian Cancer Treatment Drugs

Published by: Asia Market Information & Development Company

Published: Apr. 1, 2009 - 243 Pages

I. INTRODUCTION: Report Scope and Methodology; Executive Summary
II. BUSINESS ENVIRONMENT: Economic Outlook; Key Economic Indicators; Industrial Output; Population and Labor; Foreign Investment; Foreign Trade; Financial and Tax Regulations; Banking System and Regulations; Foreign Exchange; Taxes, Tariff and Custom Duties
III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS: Ovarian Cancer Treatment Drugs Industry Structure; Market Size; Market Growth Driver; Ovarian Cancer Treatment Drugs Sales Volume; Major Producer Facility Locations; Major Producersf Sales Volume and Market Share; Paclitaxel; Platinum Anticancer Drugs; Fluoropyrimidines; Anthracycline Antibiotics; Therapertic Antibody; Small Molecules Drug; Aromatase Inhibitors (Targeted Therapy Drug); Anti-estrogens; Aromatase Inhibitors (Endocrine Therapy Drug); LH-RH; Labor Cost; Potential Entrants; Major Distributors; Major Foreign Investments; Technology Development
IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND: Overview; Ovarian Cancer Treatment Drugs Sales Volume; Chemotherapeutic Drug; Paclitaxel; Fluoropyrimidines; Anthracycline Antibiotics; Platinum Anticancer Drugs; Targeted Therapy Drug; Therapertic Antibody; Small Molecules Drug; Aromatase Inhibitors (Targeted Therapy Drug); Endocrine Therapy Drug; Anti-estrogens; Aromatase Inhibitors (Endocrine Therapy Drug); LH|RH; Ovarian Cancer Treatment Drugs Import; Chemotherapeutic Drug; Paclitaxel; Fluoropyrimidines; Anthracycline Antibiotics; Platinum Anticancer Drugs; Targeted Therapy Drug; Therapertic Antibody; Small Molecules Drug; Aromatase Inhibitors (Targeted Therapy Drug); Endocrine Therapy Drug; Anti-estrogens; Aromatase Inhibitors (Endocrine Therapy Drug); LH|RH; Pricing Trend
V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK: Ovarian Cancer Treatment Drugs Markets Outlook Overview Concrete Government Regulations; Health Care Insurance Industry Overview; Consumer Spending Trends; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
VI. MARKET ENTRY CHANNELS: China Market Entry Overview; Chinafs Distribution System; Ovarian Cancer Treatment Drugs Distribution Channels; Transportation and Freight Infrastructure; Communications; Chinafs Market Entry; Export to China; Indirect export; Direct Export; License and Contract Manufacture; Assembling in China; Contract Manufacturing; Trade Permit; Investment; Equity Joint Venture; Contractual Joint Venture; Wholly Foreign-Owned Enterprise
VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY: Ovarian Cancer Treatment Drugs Producer Profiles and Directory
LIST OF TABLES
I. INTRODUCTION: Economic Outlook Summary
II. BUSINESS ENVIRONMENT: Key Economic Indicators; Industrial Output; Population and Labor Force Trends; Foreign Investment and Loans; Foreign Trade
III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS: Ovarian Cancer Treatment Drugs Sales Volume; Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification; Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification; Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification; Major Producer Facility Locations; Major Ovarian Cancer Treatment Drugs Producer Sales Volume and Market Share; Major Foreign Investments
IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND: Total Ovarian Cancer Treatment Drugs Sales Volume; Ovarian Cancer Treatment Drugs Major Producer and Their Market Share; Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification; Chemotherapeutic Drug Major Producer and Their Market Share; Paclitaxel Major Producer and Their Market Share; Fluoropyrimidines Major Producer and Their Market Share; Anthracycline Antibiotics Major Producer and Their Market Share; Platinum Anticancer Drugs Major Producer and Their Market Share; Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification; Targeted Therapy Drug Major Producer and Their Market Share; Therapertic Antibody Major Producer and Their Market Share; Small Molecules Drug Major Producer and Their Market Share; Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share; Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification; Endocrine Therapy Drug Major Producer and Their Market Share; Anti-estrogens Major Producer and Their Market Share; Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share; LH|RH Major Producer and Their Market Share; Ovarian Cancer Treatment Drugs Import
V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK: Consumer Spending Trends; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION: Ovarian Cancer Treatment Drugs Sales Volume

Abstract

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

2/15/2012 - 30

Chinese Markets for Ovarian Cancer Treatment Drugs

Table of Contents

Abstract